Mycoses

Introduction

Human

Veterinary

Environmental
Industrial

Agricultural

MSG

The Fungi

Introduction

Descriptions

Synonyms

Image Bank

Lecture Bank

Video Bank

Drugs

Introduction

Medical

Veterinary

Environmental
Industrial

Agricultural

Laboratory

Introduction

Susceptibility

MIC Database

Procedures

Histopathology

  Education &
  Tools

Introduction

Abbreviations

Links

CME

Conference
Highlights

Bibliography

Glossary

Good Books

Events Calendar

About Us

Introduction

Our Mission

Editorial Board

Editorial Staff

Supporters

Contributors

Legal Stuff

Kudos

The Fungi

Introduction

Descriptions

Synonyms

Image Bank

Lecture Bank

Video Bank

You are here: Education & Tools >

New Developments in the Treatment of Invasive Fungal Disease

Highlights from the 12th European Congress of Clinical Microbiology and Infectious Diseases

Goal

Learning Objectives

Accreditation Statement

Credit Designation Statement

Disclaimer Statement

Program Faculty

To provide physicians with the most current information on new advances in the treatment of invasive fungal disease.

This activity is designed for infectious disease specialists, oncologists, hematologists, critical care specialists, transplant surgeons, and interventional cardiologists. No prerequisites required.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity. At the conclusion of this activity, participants should be able to:

Identify fungal infection of the central nervous system.
Understand trends in invasive fungal infections, including trends in cryptococcosis and prevention of aspergillosis.
Monitor response to treatment and know how to decide early if a patient is failing therapy.
Understand when combinations of antifungals are beneficial.
Describe the effects of a genetically recombinant antibody against candidiasis.

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

The estimated time to complete this educational activity: 2 hours.
Release date: January 15, 2003. Expiration date: January 15, 2005.

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings and adverse effects, before administering pharmacologic therapy to patients.

Advanced Studies in Medicine (ISSN-1530-3004) is published by Galen Publishing, LLC, an HMG Company. P.O. Box 340, Somerville, NJ 08876. (908) 253-9001. Web site: www.galenpublishing.com. Copyright ©2001 by Galen Publishing, LLC. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. Bulk postage paid at Somerville, NJ Post Office and at additional mailing offices. Advanced Studies in Medicine is a registered trademark of The Healthcare Media Group, LLC. Printed on acid-free paper. BPA Membership applied for December 2000.

This CME Expires on January 15, 2005; no tests will be accepted after this date.

This course is accredited by The Office of Continuing Medical Education at Johns Hopkins University School of Medicine